Medical Weight Loss for Enterprise, Nevada Residents
Enterprise, Nevada residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Enterprise through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Enterprise Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Enterprise, Nevada residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
If you are searching for medical weight loss in Enterprise, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.
Although our clinic is physically in Costa Mesa, California, Enterprise residents receive the same physician-supervised care without leaving Nevada. We care for patients throughout Enterprise and the southern Las Vegas Valley. Compounded semaglutide and tirzepatide ship directly to your door in Nevada, and a licensed physician reviews every plan before anything is prescribed.
For Enterprise residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded medication arrives in discreet, cold-pack packaging at your Enterprise address, usually within days.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Enterprise patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Enterprise
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Enterprise address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Enterprise
Does New Hope Weight Loss treat patients in Enterprise?
Yes. Although the clinic is in Costa Mesa, California, we treat Enterprise, Nevada residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Enterprise?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Enterprise address in cold-pack packaging.
What do Enterprise patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Enterprise do you serve?
We serve patients from across Enterprise by telehealth, including Enterprise and the southern Las Vegas Valley.
Who qualifies for the program in Enterprise?
Eligibility for Enterprise patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Enterprise, Nevada by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.